204 results
Page 5 of 11
6-K
EX-99.4
6cpnrzyz
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.1
t2xb i4qmso0q4g1pv
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.2
gos9uns2 hjr9xzxqv
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.1
705 pv0ga
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
xv58o
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
zxipi1
22 Apr 20
Replicel Postpones Filing of Annual Financial Statements and MD&A Due to COVID-19 Related Delays
1:56pm
6-K
EX-99.1
9r73p rcoj
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
abw7epasvk qivgu8vo
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.5
ld40bmf
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
bean29sln6
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
bwq66ww5ow4mvm
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
owf 7zakrjff
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
0dlnc9
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
hioz1ti399vk2ew8tl
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
g8157ll h8
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
kd32a0
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
gcnt1
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
oyu2j
6 Mar 19
51-102F3 Material Change Report
4:53pm